Recent advances in T-cell engineering for use in immunotherapy [version 1; referees: 3 approved]
Adoptive T-cell therapies have shown exceptional promise in the treatment of cancer, especially B-cell malignancies. Two distinct strategies have been used to redirect the activity of ex vivo engineered T cells. In one case, the well-known ability of the T-cell receptor (TCR) to recognize a specific...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000 Research Ltd
2016-09-01
|
| Edice: | F1000Research |
| Témata: | |
| On-line přístup: | http://f1000research.com/articles/5-2344/v1 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|